• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

诱导多能干细胞来源的间充质干细胞(iMSCs)可抑制M1巨噬细胞极化,并减少与牙周炎相关的牙槽骨丧失。

Induced pluripotent stem cell-derived mesenchymal stem cells (iMSCs) inhibit M1 macrophage polarization and reduce alveolar bone loss associated with periodontitis.

作者信息

Chen Liang, Liu Yuanqing, Yu Chenhao, Cao Pei, Ma Yiming, Geng Yiran, Cai Yu, Zhang Yong, Liu Jia, Li Yang, Luan Qingxian

机构信息

Department of Periodontology, Peking University School and Hospital of Stomatology & National Center for Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Laboratory for Digital and Material Technology of Stomatology, No. 22, Zhongguancun South Avenue, Haidian District, Beijing, 100081, People's Republic of China.

First Clinical Division, Peking University School and Hospital of Stomatology & National Center for Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Laboratory for Digital and Material Technology of Stomatology, No. 22, Zhongguancun South Avenue, Haidian District, Beijing, 100081, People's Republic of China.

出版信息

Stem Cell Res Ther. 2025 May 2;16(1):223. doi: 10.1186/s13287-025-04327-0.

DOI:10.1186/s13287-025-04327-0
PMID:40317064
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12046914/
Abstract

BACKGROUND

Periodontitis is a chronic inflammatory disease and macrophages play a pivotal role in the progression of periodontitis. Mesenchymal stem cells (MSCs) have emerged as potential therapeutic agents for the treatment of periodontitis due to their immunomodulatory properties and capacity for tissue regeneration. Compared to conventionally derived MSCs, induced pluripotent stem cell-derived MSCs (iMSCs) offer distinct advantages as promising candidates for MSC-based therapies, owing to their non-invasive acquisition methods and virtually unlimited availability. This study aims to investigate the effects and mechanisms of iMSCs in modulating macrophage polarization and alleviating periodontitis-related alveolar bone loss.

METHODS

iMSCs were generated from iPSCs and characterized for differentiation potential. The effects of iMSCs on macrophage polarization were evaluated using THP-1-derived macrophages under inflammatory conditions (LPS and IFN-γ stimulation). Co-culture assays, cytokine analysis, reactive oxygen species (ROS) detection, transcriptomic analysis, flow cytometry, reverse transcription-quantitative polymerase chain reaction (RT-qPCR), and western blot analysis were performed to elucidate the underlying mechanisms. The therapeutic potential of iMSCs was assessed in a ligature-induced periodontitis mouse model using micro-CT, histological analysis, and immunofluorescence staining.

RESULTS

iMSCs inhibit M1 macrophage polarization through the suppression of the NF-κB signaling pathway. Additionally, iMSCs reduce the production of pro-inflammatory cytokines (IL-1β, IL-17) and reactive oxygen species (ROS), while enhancing the secretion of anti-inflammatory cytokines (IL-10) and growth factors (VEGF), thereby improving the inflammatory microenvironment. Under inflammatory conditions, iMSCs preserve the osteogenic potential of periodontal ligament stem cells (PDLSCs) and alleviate alveolar bone loss in mice with periodontitis. In vivo, iMSCs reduce the number of M1 macrophages and inhibit the activation of NF-κB in periodontal tissues, supporting their anti-inflammatory and immunomodulatory effects.

CONCLUSION

iMSCs demonstrate significant therapeutic potential in periodontitis by modulating macrophage polarization, reducing oxidative stress, and mitigating alveolar bone loss associated with the disease. These findings provide new insights into the mechanisms of iMSCs and their application as cell-based therapies for periodontal diseases.

摘要

背景

牙周炎是一种慢性炎症性疾病,巨噬细胞在牙周炎的进展中起关键作用。间充质干细胞(MSCs)因其免疫调节特性和组织再生能力,已成为治疗牙周炎的潜在治疗剂。与传统来源的MSCs相比,诱导多能干细胞来源的MSCs(iMSCs)因其非侵入性获取方法和几乎无限的可用性,作为基于MSCs治疗的有前途的候选者具有明显优势。本研究旨在探讨iMSCs在调节巨噬细胞极化和减轻牙周炎相关牙槽骨丧失中的作用及机制。

方法

从诱导多能干细胞(iPSCs)中生成iMSCs,并对其分化潜能进行表征。在炎症条件下(脂多糖和干扰素-γ刺激),使用THP-1来源的巨噬细胞评估iMSCs对巨噬细胞极化的影响。进行共培养试验、细胞因子分析、活性氧(ROS)检测、转录组分析、流式细胞术、逆转录定量聚合酶链反应(RT-qPCR)和蛋白质印迹分析以阐明潜在机制。使用显微计算机断层扫描(micro-CT)、组织学分析和免疫荧光染色,在结扎诱导的牙周炎小鼠模型中评估iMSCs的治疗潜力。

结果

iMSCs通过抑制核因子-κB(NF-κB)信号通路抑制M1巨噬细胞极化。此外,iMSCs减少促炎细胞因子(白细胞介素-1β、白细胞介素-17)和活性氧(ROS)的产生,同时增强抗炎细胞因子(白细胞介素-10)和生长因子(血管内皮生长因子)的分泌,从而改善炎症微环境。在炎症条件下,iMSCs保留牙周膜干细胞(PDLSCs)的成骨潜能,并减轻牙周炎小鼠的牙槽骨丧失。在体内,iMSCs减少牙周组织中M1巨噬细胞的数量并抑制NF-κB的激活,支持其抗炎和免疫调节作用。

结论

iMSCs通过调节巨噬细胞极化、降低氧化应激和减轻与该疾病相关的牙槽骨丧失,在牙周炎中显示出显著的治疗潜力。这些发现为iMSCs的机制及其作为牙周疾病基于细胞的治疗方法的应用提供了新的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfd3/12046914/59620f77f4cc/13287_2025_4327_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfd3/12046914/acfe3fe4fc7a/13287_2025_4327_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfd3/12046914/0480db989c3f/13287_2025_4327_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfd3/12046914/b81514357863/13287_2025_4327_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfd3/12046914/887d8bdbf373/13287_2025_4327_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfd3/12046914/e13833361f94/13287_2025_4327_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfd3/12046914/975beb1a072d/13287_2025_4327_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfd3/12046914/7ded997adf71/13287_2025_4327_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfd3/12046914/59620f77f4cc/13287_2025_4327_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfd3/12046914/acfe3fe4fc7a/13287_2025_4327_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfd3/12046914/0480db989c3f/13287_2025_4327_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfd3/12046914/b81514357863/13287_2025_4327_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfd3/12046914/887d8bdbf373/13287_2025_4327_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfd3/12046914/e13833361f94/13287_2025_4327_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfd3/12046914/975beb1a072d/13287_2025_4327_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfd3/12046914/7ded997adf71/13287_2025_4327_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfd3/12046914/59620f77f4cc/13287_2025_4327_Fig8_HTML.jpg

相似文献

1
Induced pluripotent stem cell-derived mesenchymal stem cells (iMSCs) inhibit M1 macrophage polarization and reduce alveolar bone loss associated with periodontitis.诱导多能干细胞来源的间充质干细胞(iMSCs)可抑制M1巨噬细胞极化,并减少与牙周炎相关的牙槽骨丧失。
Stem Cell Res Ther. 2025 May 2;16(1):223. doi: 10.1186/s13287-025-04327-0.
2
Therapeutic effect of TSG-6 engineered iPSC-derived MSCs on experimental periodontitis in rats: a pilot study.TSG-6 工程化诱导多能干细胞来源的间充质干细胞对大鼠实验性牙周炎的治疗作用:一项初步研究。
PLoS One. 2014 Jun 30;9(6):e100285. doi: 10.1371/journal.pone.0100285. eCollection 2014.
3
Downregulation of Macrophage-Specific Act-1 Intensifies Periodontitis and Alveolar Bone Loss Possibly via TNF/NF-κB Signaling.巨噬细胞特异性Act-1的下调可能通过TNF/NF-κB信号通路加剧牙周炎和牙槽骨丧失。
Front Cell Dev Biol. 2021 Mar 4;9:628139. doi: 10.3389/fcell.2021.628139. eCollection 2021.
4
BPIFA1 inhibits periodontitis by regulating the NF-κB/IκB signaling pathway and macrophage M1/M2 polarization.BPIFA1通过调节NF-κB/IκB信号通路和巨噬细胞M1/M2极化来抑制牙周炎。
Arch Oral Biol. 2025 May;173:106190. doi: 10.1016/j.archoralbio.2025.106190. Epub 2025 Feb 12.
5
Lipopolysaccharide differentially affects the osteogenic differentiation of periodontal ligament stem cells and bone marrow mesenchymal stem cells through Toll-like receptor 4 mediated nuclear factor κB pathway.脂多糖通过Toll样受体4介导的核因子κB途径对牙周膜干细胞和成人间充质干细胞的成骨分化产生不同影响。
Stem Cell Res Ther. 2014 May 27;5(3):67. doi: 10.1186/scrt456.
6
FoxO1-Overexpressed Small Extracellular Vesicles Derived from hPDLSCs Promote Periodontal Tissue Regeneration by Reducing Mitochondrial Dysfunction to Regulate Osteogenesis and Inflammation.FoxO1 过表达的人牙周膜干细胞来源的小细胞外囊泡通过减轻线粒体功能障碍来调节成骨和炎症,促进牙周组织再生。
Int J Nanomedicine. 2024 Aug 27;19:8751-8768. doi: 10.2147/IJN.S470419. eCollection 2024.
7
Periodontal ligament stem cells promote polarization of M2 macrophages.牙周膜干细胞促进 M2 巨噬细胞的极化。
J Leukoc Biol. 2022 Jun;111(6):1185-1197. doi: 10.1002/JLB.1MA1220-853RR. Epub 2022 Jan 4.
8
Unveiling the Immunomodulatory and regenerative potential of iPSC-derived mesenchymal stromal cells and their extracellular vesicles.揭示 iPSC 来源的间充质基质细胞及其细胞外囊泡的免疫调节和再生潜力。
Sci Rep. 2024 Oct 15;14(1):24098. doi: 10.1038/s41598-024-75956-3.
9
Mesenchymal Stem Cells Derived from Human Urine-Derived iPSCs Exhibit Low Immunogenicity and Reduced Immunomodulatory Profile.人尿液来源诱导多能干细胞衍生的间充质干细胞表现出低免疫原性和降低的免疫调节特性。
Int J Mol Sci. 2024 Sep 27;25(19):10394. doi: 10.3390/ijms251910394.
10
HIF-1α activator DMOG inhibits alveolar bone resorption in murine periodontitis by regulating macrophage polarization.HIF-1α 激活剂 DMOG 通过调节巨噬细胞极化抑制牙周炎牙槽骨吸收。
Int Immunopharmacol. 2021 Oct;99:107901. doi: 10.1016/j.intimp.2021.107901. Epub 2021 Jul 14.

引用本文的文献

1
From mitochondria to immune networks: new mesenchymal stem cell strategies to treat periodontitis.从线粒体到免疫网络:治疗牙周炎的间充质干细胞新策略
Stem Cell Res Ther. 2025 Aug 29;16(1):470. doi: 10.1186/s13287-025-04619-5.

本文引用的文献

1
Pharmacokinetic characteristics of mesenchymal stem cells in translational challenges.间充质干细胞在转化挑战中的药代动力学特征。
Signal Transduct Target Ther. 2024 Sep 13;9(1):242. doi: 10.1038/s41392-024-01936-8.
2
A new direction in periodontitis treatment: biomaterial-mediated macrophage immunotherapy.牙周炎治疗的新方向:生物材料介导的巨噬细胞免疫疗法。
J Nanobiotechnology. 2024 Jun 21;22(1):359. doi: 10.1186/s12951-024-02592-4.
3
Two-year safety outcomes of iPS cell-derived mesenchymal stromal cells in acute steroid-resistant graft-versus-host disease.
iPS 细胞来源的间充质基质细胞治疗急性激素耐药移植物抗宿主病的 2 年安全性结果。
Nat Med. 2024 Jun;30(6):1556-1558. doi: 10.1038/s41591-024-02990-z. Epub 2024 May 22.
4
TPG-functionalized PLGA/PCL nanofiber membrane facilitates periodontal tissue regeneration by modulating macrophages polarization via suppressing PI3K/AKT and NF-κB signaling pathways.TPG功能化的聚乳酸-乙醇酸共聚物/聚己内酯纳米纤维膜通过抑制PI3K/AKT和NF-κB信号通路来调节巨噬细胞极化,从而促进牙周组织再生。
Mater Today Bio. 2024 Apr 2;26:101036. doi: 10.1016/j.mtbio.2024.101036. eCollection 2024 Jun.
5
Exosomes from SHED-MSC regulate polarization and stress oxidative indexes in THP-1 derived M1 macrophages.脱落乳牙间充质干细胞来源的外泌体调节THP-1衍生的M1巨噬细胞的极化和氧化应激指标。
Arch Biochem Biophys. 2024 May;755:109987. doi: 10.1016/j.abb.2024.109987. Epub 2024 Apr 4.
6
Impaired bisecting GlcNAc reprogrammed M1 polarization of macrophage.受损的平分型N-乙酰葡糖胺重编程巨噬细胞的M1极化。
Cell Commun Signal. 2024 Jan 26;22(1):73. doi: 10.1186/s12964-023-01432-6.
7
Advances in Mesenchymal stem cells regulating macrophage polarization and treatment of sepsis-induced liver injury.间质干细胞在调节巨噬细胞极化和治疗脓毒症相关性肝损伤中的研究进展。
Front Immunol. 2023 Oct 25;14:1238972. doi: 10.3389/fimmu.2023.1238972. eCollection 2023.
8
iPSC-derived mesenchymal stem cells attenuate cerebral ischemia-reperfusion injury by inhibiting inflammatory signaling and oxidative stress.诱导多能干细胞衍生的间充质干细胞通过抑制炎症信号传导和氧化应激减轻脑缺血再灌注损伤。
Mol Ther Methods Clin Dev. 2023 Jul 15;30:333-349. doi: 10.1016/j.omtm.2023.07.005. eCollection 2023 Sep 14.
9
Mesenchymal stem cells shift the pro-inflammatory phenotype of neutrophils to ameliorate acute lung injury.间充质干细胞将中性粒细胞的促炎表型转变为减轻急性肺损伤。
Stem Cell Res Ther. 2023 Aug 8;14(1):197. doi: 10.1186/s13287-023-03438-w.
10
MSC therapy ameliorates experimental gouty arthritis hinting an early COX-2 induction.MSC 疗法改善实验性痛风性关节炎提示早期 COX-2 诱导。
Front Immunol. 2023 Jul 18;14:1193179. doi: 10.3389/fimmu.2023.1193179. eCollection 2023.